Funding Opportunities

• Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)
  (PA-19-200)
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Heart, Lung, and Blood Institute
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)
  (PA-19-201)
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 16, 2019 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional)
  (PA-19-205)
  Office of Research on Women's Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): April 8, 2019 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
  (PAR-19-197)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): April 23, 2019, March 17, 2020, March 17 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)
  (PAR-19-198)
  National Cancer Institute
  Application Receipt Date(s): June 10, 2019; November 6, 2019; June 10, 2020; November 6 2020; June 10, 2021; November 8, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)
  (PAR-19-199)
  National Cancer Institute
  Application Receipt Date(s): June 10, 2019; November 6, 2019; June 10, 2020; November 6 2020; June 10, 2021; November 8, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• High impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
  (PAR-19-202)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): May 30, 2019; October 31, 2019; June 2, 2020; November 3, 2020; June 1, 2021; November 2, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Not Allowed)
  (PAR-19-203)
  National Eye Institute
  Application Receipt Date(s): April 15, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional)
  (PAR-19-204)
  National Human Genome Research Institute
  National Institute of Mental Health
  Application Receipt Date(s): May 20, 2019; March 26, 2020; May 18, 2020; November 20, 2020; May 20, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Renewal of the Aging Interventions Testing Program (U01 Clinical Trial Not Allowed)
  (RFA-AG-19-030)
  National Institute on Aging
  Application Receipt Date(s): May 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Interventions Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-AG-19-031)
  National Institute on Aging
  Application Receipt Date(s): May 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed)
  (RFA-AI-19-010)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 31, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed)
  (RFA-MH-20-115)
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• Clinical and Biological Measures of TBI-related dementia including Chronic Traumatic Encephalopathy (CTE) (R01 Clinical Trial Not Allowed)
  (RFA-NS-19-026)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): April 15, 2019, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement.
• Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive decline - Center Without Walls (NATBI CWOW) (U54 Clinical Trial Not Allowed)
  (RFA-NS-19-030)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): April 15, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.